Hypertension and sleep apnea in black South Africans - A case control study

被引:10
作者
Bartel, PR
Loock, M
vanderMeyden, C
Robinson, E
Becker, P
机构
[1] Department of Neurology, University of Pretoria, HF Verwoerd Hospital, Pretoria
[2] Department of Internal Medicine, University of Pretoria, Kalafong Hospital, Pretoria
[3] Centre for Epidemiological Research in Southern Africa, Medical Research Council, Pretoria
关键词
sleep apnea; hypertension; anthropometry; demography;
D O I
10.1016/0895-7061(95)00387-8
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Despite relatively consistent findings that patients with hypertension have higher than anticipated prevalences of sleep apneal/hypopnea (SAH), inadequately controlled factors such as age and obesity have been implicated as possibly accounting for these findings. All-night polysomnograms were performed on 20 hypertensive black South Africans, a group with increased risk for this disease. They were matched with a control group of black subjects in respect of age, gender, body mass index (BMI), neck circumference and scores on a sleep questionnaire. While the groups failed to differ significantly in terms of demographic variables, nor in regard to 8/9 anthropometric measures, the hypertensive group had a significantly higher apneal/hypopnea index (AH) (P =.01), longer duration of AH (P =.01) and lower mean minimum arterial oxygen saturation levels (P =.005). Of the anthropometric measures, only age and neck circumference were found to be cofactors for AHI and were accounted for in the analysis. Five of the hypertensive patients and two of the controls had an AHI >10, giving a prevalence odds ratio of 3 (95% confidence interval: 0.66-14.50). The present study appears to be the first in black African subjects and with prevalence findings largely comparable to those obtained in other ethnic groups. There was a trend for more severe SAH to occur in this subgroup of five hypertensives (AHI - 14-30) than in controls (maximum AHI = 12). While data are lacking to link antihypertensive medication to SAH in humans, further study is necessary before discarding this factor.
引用
收藏
页码:1200 / 1205
页数:6
相关论文
共 34 条
[1]  
Guilleminault, Tilkian, Dement, The sleep apnea syndromes, Annu Rev Med, 27, pp. 465-484, (1976)
[2]  
Hoffstein, Chan, Slutsky, Sleep apnea and systemic hypertension: a causal association review, Am J Med, 91, pp. 190-196, (1991)
[3]  
Warley, Mitchell, Stradling, Prevalence of nocturnal hypoxaemia amongst men with mild to moderate hypertension, Q J Med, 68, pp. 637-644, (1988)
[4]  
Lavie, Ben-Yosef, Rubin, Prevalence of sleep apnea syndrome among patients with essential hypertension, Am Heart J, 108, pp. 373-376, (1984)
[5]  
Kales, Bixler, Cadieux, Et al., Sleep apnea in a hypertensive population, Lancet, 2, pp. 1005-1008, (1984)
[6]  
Williams, Houston, Finberg, Et al., Sleep apnea syndrome and essential hypertension, Am J Cardiol, 55, pp. 1019-1022, (1985)
[7]  
Fletcher, Debehnke, Lovoi, Et al., Undiagnosed sleep apnea in patients with essential hypertension, Ann Intern Med, 103, pp. 190-195, (1985)
[8]  
Hirshkowitz, Karacan, Gurakar, Et al., Hypertension, erectile dysfunction, and occult sleep apnea, Sleep, 12, pp. 223-232, (1989)
[9]  
Guilleminault, Suzuki, Sleep-related hemodynamics and hypertension with partial or complete upper airway obstruction during sleep, Sleep, 15, pp. S20-S24, (1992)
[10]  
Wilcox, Grunstein, Hedner, Et al., Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea, Sleep, 16, pp. 539-544, (1993)